Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-058860

Options or other derivatives

  • Chief Legal Officer acquired 325,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wilson Mark Andrew · Chief Legal Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-12-13 Grant or award : show line 1 in the form Stock Option +325,000 325,000 D
Loading xslF345X05/doc4.xml…